nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Vemurafenib—melanoma	0.316	0.447	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—melanoma	0.21	0.297	CbGbCtD
Idarubicin—ABCC1—Docetaxel—melanoma	0.108	0.154	CbGbCtD
Idarubicin—CYP2D6—Vemurafenib—melanoma	0.0719	0.102	CbGbCtD
Idarubicin—Radiation injury—Dactinomycin—melanoma	0.0115	0.0484	CcSEcCtD
Idarubicin—Radiation injury—Temozolomide—melanoma	0.0104	0.0438	CcSEcCtD
Idarubicin—Neutropenic enterocolitis—Docetaxel—melanoma	0.0101	0.0424	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Dactinomycin—melanoma	0.00736	0.031	CcSEcCtD
Idarubicin—Recall phenomenon—Dactinomycin—melanoma	0.00697	0.0293	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Carmustine—melanoma	0.00689	0.029	CcSEcCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Docetaxel—melanoma	0.0063	0.0265	CcSEcCtD
Idarubicin—Neutropenic colitis—Docetaxel—melanoma	0.0063	0.0265	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Temozolomide—melanoma	0.00544	0.0229	CcSEcCtD
Idarubicin—Rash generalised—Vemurafenib—melanoma	0.00503	0.0212	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Docetaxel—melanoma	0.00443	0.0186	CcSEcCtD
Idarubicin—Recall phenomenon—Docetaxel—melanoma	0.00419	0.0176	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Docetaxel—melanoma	0.00362	0.0152	CcSEcCtD
Idarubicin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.00359	1	CbGdCrCtD
Idarubicin—Epirubicin—AURKA—melanoma	0.00357	0.4	CrCbGaD
Idarubicin—Cardiotoxicity—Docetaxel—melanoma	0.00308	0.013	CcSEcCtD
Idarubicin—Myelosuppression—Bleomycin—melanoma	0.00276	0.0116	CcSEcCtD
Idarubicin—Enterocolitis—Docetaxel—melanoma	0.00262	0.011	CcSEcCtD
Idarubicin—Myelosuppression—Dactinomycin—melanoma	0.00258	0.0108	CcSEcCtD
Idarubicin—Myelosuppression—Carmustine—melanoma	0.00241	0.0101	CcSEcCtD
Idarubicin—Local reaction—Bleomycin—melanoma	0.00234	0.00984	CcSEcCtD
Idarubicin—Mucosal inflammation—Bleomycin—melanoma	0.00234	0.00984	CcSEcCtD
Idarubicin—Myelosuppression—Temozolomide—melanoma	0.00233	0.0098	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Bleomycin—melanoma	0.00218	0.00916	CcSEcCtD
Idarubicin—Febrile neutropenia—Bleomycin—melanoma	0.00215	0.00906	CcSEcCtD
Idarubicin—Doxorubicin—AURKA—melanoma	0.00205	0.23	CrCbGaD
Idarubicin—Febrile neutropenia—Dactinomycin—melanoma	0.00201	0.00845	CcSEcCtD
Idarubicin—Neoplasm—Vemurafenib—melanoma	0.00193	0.00813	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Carmustine—melanoma	0.0019	0.008	CcSEcCtD
Idarubicin—Febrile neutropenia—Carmustine—melanoma	0.00188	0.00791	CcSEcCtD
Idarubicin—Febrile neutropenia—Temozolomide—melanoma	0.00182	0.00764	CcSEcCtD
Idarubicin—Sinus tachycardia—Docetaxel—melanoma	0.0018	0.00759	CcSEcCtD
Idarubicin—Rash generalised—Docetaxel—melanoma	0.00171	0.00719	CcSEcCtD
Idarubicin—Embolism—Temozolomide—melanoma	0.0017	0.00716	CcSEcCtD
Idarubicin—Atrial fibrillation—Vemurafenib—melanoma	0.00164	0.00689	CcSEcCtD
Idarubicin—Burning sensation—Carmustine—melanoma	0.00163	0.00685	CcSEcCtD
Idarubicin—Myelosuppression—Docetaxel—melanoma	0.00155	0.00652	CcSEcCtD
Idarubicin—Necrosis—Dactinomycin—melanoma	0.00154	0.00647	CcSEcCtD
Idarubicin—Extravasation—Bleomycin—melanoma	0.00148	0.00625	CcSEcCtD
Idarubicin—Necrosis—Carmustine—melanoma	0.00144	0.00606	CcSEcCtD
Idarubicin—Extravasation—Dactinomycin—melanoma	0.00138	0.00582	CcSEcCtD
Idarubicin—Ulcer—Bleomycin—melanoma	0.00137	0.00576	CcSEcCtD
Idarubicin—Mucosal inflammation—Docetaxel—melanoma	0.00131	0.00552	CcSEcCtD
Idarubicin—Extravasation—Carmustine—melanoma	0.0013	0.00545	CcSEcCtD
Idarubicin—Ulcer—Dactinomycin—melanoma	0.00128	0.00537	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Docetaxel—melanoma	0.00122	0.00514	CcSEcCtD
Idarubicin—Febrile neutropenia—Docetaxel—melanoma	0.00121	0.00508	CcSEcCtD
Idarubicin—Embolism—Docetaxel—melanoma	0.00113	0.00476	CcSEcCtD
Idarubicin—Oesophagitis—Dactinomycin—melanoma	0.0011	0.00464	CcSEcCtD
Idarubicin—Phlebitis—Bleomycin—melanoma	0.00109	0.00459	CcSEcCtD
Idarubicin—Sepsis—Dactinomycin—melanoma	0.00105	0.00441	CcSEcCtD
Idarubicin—Burning sensation—Docetaxel—melanoma	0.00105	0.0044	CcSEcCtD
Idarubicin—Neoplasm—Carmustine—melanoma	0.00102	0.0043	CcSEcCtD
Idarubicin—Phlebitis—Dactinomycin—melanoma	0.00102	0.00428	CcSEcCtD
Idarubicin—Daunorubicin—CYP1B1—melanoma	0.00101	0.113	CrCbGaD
Idarubicin—Neoplasm—Temozolomide—melanoma	0.000988	0.00416	CcSEcCtD
Idarubicin—Sepsis—Carmustine—melanoma	0.000981	0.00413	CcSEcCtD
Idarubicin—Angiopathy—Vemurafenib—melanoma	0.000974	0.0041	CcSEcCtD
Idarubicin—Chills—Vemurafenib—melanoma	0.000963	0.00405	CcSEcCtD
Idarubicin—Doxorubicin—NOS2—melanoma	0.000961	0.108	CrCbGaD
Idarubicin—Phlebitis—Carmustine—melanoma	0.000953	0.00401	CcSEcCtD
Idarubicin—Alopecia—Vemurafenib—melanoma	0.000949	0.00399	CcSEcCtD
Idarubicin—Thrombophlebitis—Carmustine—melanoma	0.000948	0.00399	CcSEcCtD
Idarubicin—Malnutrition—Vemurafenib—melanoma	0.000935	0.00393	CcSEcCtD
Idarubicin—Necrosis—Docetaxel—melanoma	0.000926	0.00389	CcSEcCtD
Idarubicin—Thrombophlebitis—Temozolomide—melanoma	0.000916	0.00385	CcSEcCtD
Idarubicin—Hot flush—Temozolomide—melanoma	0.000848	0.00357	CcSEcCtD
Idarubicin—Menopausal symptoms—Temozolomide—melanoma	0.000841	0.00354	CcSEcCtD
Idarubicin—Extravasation—Docetaxel—melanoma	0.000833	0.0035	CcSEcCtD
Idarubicin—Doxorubicin—CYP1B1—melanoma	0.000817	0.0914	CrCbGaD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00079	0.00332	CcSEcCtD
Idarubicin—Pancytopenia—Bleomycin—melanoma	0.000772	0.00325	CcSEcCtD
Idarubicin—Anaphylactic shock—Vemurafenib—melanoma	0.000763	0.00321	CcSEcCtD
Idarubicin—Infection—Vemurafenib—melanoma	0.000758	0.00319	CcSEcCtD
Idarubicin—Skin disorder—Vemurafenib—melanoma	0.000741	0.00312	CcSEcCtD
Idarubicin—Dehydration—Temozolomide—melanoma	0.000738	0.0031	CcSEcCtD
Idarubicin—Pancytopenia—Dactinomycin—melanoma	0.00072	0.00303	CcSEcCtD
Idarubicin—Acute coronary syndrome—Bleomycin—melanoma	0.000714	0.003	CcSEcCtD
Idarubicin—Myocardial infarction—Bleomycin—melanoma	0.00071	0.00299	CcSEcCtD
Idarubicin—Neutropenia—Dactinomycin—melanoma	0.000709	0.00298	CcSEcCtD
Idarubicin—Stomatitis—Bleomycin—melanoma	0.000706	0.00297	CcSEcCtD
Idarubicin—Colitis—Docetaxel—melanoma	0.000698	0.00293	CcSEcCtD
Idarubicin—Pancytopenia—Carmustine—melanoma	0.000674	0.00283	CcSEcCtD
Idarubicin—Oesophagitis—Docetaxel—melanoma	0.000664	0.00279	CcSEcCtD
Idarubicin—Neutropenia—Carmustine—melanoma	0.000663	0.00279	CcSEcCtD
Idarubicin—Decreased appetite—Vemurafenib—melanoma	0.000663	0.00279	CcSEcCtD
Idarubicin—Stomatitis—Dactinomycin—melanoma	0.000659	0.00277	CcSEcCtD
Idarubicin—Neoplasm—Docetaxel—melanoma	0.000657	0.00276	CcSEcCtD
Idarubicin—Haemoglobin—Bleomycin—melanoma	0.000654	0.00275	CcSEcCtD
Idarubicin—Pancytopenia—Temozolomide—melanoma	0.000651	0.00274	CcSEcCtD
Idarubicin—Haemorrhage—Bleomycin—melanoma	0.00065	0.00274	CcSEcCtD
Idarubicin—Neutropenia—Temozolomide—melanoma	0.000641	0.0027	CcSEcCtD
Idarubicin—Sepsis—Docetaxel—melanoma	0.000631	0.00265	CcSEcCtD
Idarubicin—Stomatitis—Carmustine—melanoma	0.000617	0.00259	CcSEcCtD
Idarubicin—Phlebitis—Docetaxel—melanoma	0.000612	0.00258	CcSEcCtD
Idarubicin—Thrombophlebitis—Docetaxel—melanoma	0.000609	0.00256	CcSEcCtD
Idarubicin—Flushing—Bleomycin—melanoma	0.000604	0.00254	CcSEcCtD
Idarubicin—Body temperature increased—Vemurafenib—melanoma	0.000603	0.00254	CcSEcCtD
Idarubicin—Stomatitis—Temozolomide—melanoma	0.000596	0.00251	CcSEcCtD
Idarubicin—Chills—Bleomycin—melanoma	0.000584	0.00246	CcSEcCtD
Idarubicin—Cardiac failure congestive—Docetaxel—melanoma	0.000582	0.00245	CcSEcCtD
Idarubicin—Alopecia—Bleomycin—melanoma	0.000575	0.00242	CcSEcCtD
Idarubicin—Haemoglobin—Carmustine—melanoma	0.000571	0.0024	CcSEcCtD
Idarubicin—Haemorrhage—Carmustine—melanoma	0.000568	0.00239	CcSEcCtD
Idarubicin—Hot flush—Docetaxel—melanoma	0.000564	0.00237	CcSEcCtD
Idarubicin—Flushing—Dactinomycin—melanoma	0.000563	0.00237	CcSEcCtD
Idarubicin—Hypersensitivity—Vemurafenib—melanoma	0.000562	0.00236	CcSEcCtD
Idarubicin—Menopausal symptoms—Docetaxel—melanoma	0.000559	0.00235	CcSEcCtD
Idarubicin—Atrial fibrillation—Docetaxel—melanoma	0.000557	0.00234	CcSEcCtD
Idarubicin—Haemoglobin—Temozolomide—melanoma	0.000551	0.00232	CcSEcCtD
Idarubicin—Haemorrhage—Temozolomide—melanoma	0.000549	0.00231	CcSEcCtD
Idarubicin—Chills—Dactinomycin—melanoma	0.000544	0.00229	CcSEcCtD
Idarubicin—Urinary tract disorder—Temozolomide—melanoma	0.000542	0.00228	CcSEcCtD
Idarubicin—Urethral disorder—Temozolomide—melanoma	0.000538	0.00226	CcSEcCtD
Idarubicin—Alopecia—Dactinomycin—melanoma	0.000536	0.00226	CcSEcCtD
Idarubicin—Flushing—Carmustine—melanoma	0.000527	0.00222	CcSEcCtD
Idarubicin—Anaemia—Bleomycin—melanoma	0.000523	0.0022	CcSEcCtD
Idarubicin—Diarrhoea—Vemurafenib—melanoma	0.000522	0.0022	CcSEcCtD
Idarubicin—Flushing—Temozolomide—melanoma	0.000509	0.00214	CcSEcCtD
Idarubicin—Arrhythmia—Carmustine—melanoma	0.000507	0.00213	CcSEcCtD
Idarubicin—Leukopenia—Bleomycin—melanoma	0.000507	0.00213	CcSEcCtD
Idarubicin—Alopecia—Carmustine—melanoma	0.000502	0.00211	CcSEcCtD
Idarubicin—Angiopathy—Temozolomide—melanoma	0.000498	0.00209	CcSEcCtD
Idarubicin—Immune system disorder—Temozolomide—melanoma	0.000496	0.00208	CcSEcCtD
Idarubicin—Malnutrition—Carmustine—melanoma	0.000494	0.00208	CcSEcCtD
Idarubicin—Chills—Temozolomide—melanoma	0.000492	0.00207	CcSEcCtD
Idarubicin—Dehydration—Docetaxel—melanoma	0.000491	0.00206	CcSEcCtD
Idarubicin—Anaemia—Dactinomycin—melanoma	0.000488	0.00205	CcSEcCtD
Idarubicin—Vomiting—Vemurafenib—melanoma	0.000485	0.00204	CcSEcCtD
Idarubicin—Alopecia—Temozolomide—melanoma	0.000485	0.00204	CcSEcCtD
Idarubicin—Chest pain—Bleomycin—melanoma	0.000482	0.00203	CcSEcCtD
Idarubicin—Rash—Vemurafenib—melanoma	0.000481	0.00202	CcSEcCtD
Idarubicin—Dermatitis—Vemurafenib—melanoma	0.000481	0.00202	CcSEcCtD
Idarubicin—Headache—Vemurafenib—melanoma	0.000478	0.00201	CcSEcCtD
Idarubicin—Malnutrition—Temozolomide—melanoma	0.000478	0.00201	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—melanoma	0.000473	0.00199	CcSEcCtD
Idarubicin—Anaphylactic shock—Bleomycin—melanoma	0.000462	0.00194	CcSEcCtD
Idarubicin—Infection—Bleomycin—melanoma	0.000459	0.00193	CcSEcCtD
Idarubicin—Anaemia—Carmustine—melanoma	0.000457	0.00192	CcSEcCtD
Idarubicin—Nausea—Vemurafenib—melanoma	0.000453	0.00191	CcSEcCtD
Idarubicin—Thrombocytopenia—Bleomycin—melanoma	0.000452	0.0019	CcSEcCtD
Idarubicin—Leukopenia—Carmustine—melanoma	0.000442	0.00186	CcSEcCtD
Idarubicin—Anaemia—Temozolomide—melanoma	0.000441	0.00186	CcSEcCtD
Idarubicin—Anorexia—Bleomycin—melanoma	0.000441	0.00185	CcSEcCtD
Idarubicin—Pancytopenia—Docetaxel—melanoma	0.000433	0.00182	CcSEcCtD
Idarubicin—Convulsion—Carmustine—melanoma	0.000428	0.0018	CcSEcCtD
Idarubicin—Infection—Dactinomycin—melanoma	0.000428	0.0018	CcSEcCtD
Idarubicin—Leukopenia—Temozolomide—melanoma	0.000428	0.0018	CcSEcCtD
Idarubicin—Neutropenia—Docetaxel—melanoma	0.000426	0.00179	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—melanoma	0.000422	0.00178	CcSEcCtD
Idarubicin—Chest pain—Carmustine—melanoma	0.000421	0.00177	CcSEcCtD
Idarubicin—Convulsion—Temozolomide—melanoma	0.000414	0.00174	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—melanoma	0.000411	0.00173	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000404	0.0017	CcSEcCtD
Idarubicin—Decreased appetite—Bleomycin—melanoma	0.000402	0.00169	CcSEcCtD
Idarubicin—Infection—Carmustine—melanoma	0.000401	0.00169	CcSEcCtD
Idarubicin—Acute coronary syndrome—Docetaxel—melanoma	0.000401	0.00169	CcSEcCtD
Idarubicin—Myocardial infarction—Docetaxel—melanoma	0.000398	0.00168	CcSEcCtD
Idarubicin—Stomatitis—Docetaxel—melanoma	0.000396	0.00167	CcSEcCtD
Idarubicin—Thrombocytopenia—Carmustine—melanoma	0.000395	0.00166	CcSEcCtD
Idarubicin—Anaphylactic shock—Temozolomide—melanoma	0.00039	0.00164	CcSEcCtD
Idarubicin—Infection—Temozolomide—melanoma	0.000387	0.00163	CcSEcCtD
Idarubicin—Anorexia—Carmustine—melanoma	0.000385	0.00162	CcSEcCtD
Idarubicin—Thrombocytopenia—Temozolomide—melanoma	0.000382	0.00161	CcSEcCtD
Idarubicin—Skin disorder—Temozolomide—melanoma	0.000379	0.00159	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—melanoma	0.000375	0.00158	CcSEcCtD
Idarubicin—Anorexia—Temozolomide—melanoma	0.000372	0.00156	CcSEcCtD
Idarubicin—Urticaria—Bleomycin—melanoma	0.000367	0.00154	CcSEcCtD
Idarubicin—Haemoglobin—Docetaxel—melanoma	0.000367	0.00154	CcSEcCtD
Idarubicin—Body temperature increased—Bleomycin—melanoma	0.000365	0.00154	CcSEcCtD
Idarubicin—Haemorrhage—Docetaxel—melanoma	0.000365	0.00154	CcSEcCtD
Idarubicin—Urinary tract disorder—Docetaxel—melanoma	0.00036	0.00152	CcSEcCtD
Idarubicin—Urethral disorder—Docetaxel—melanoma	0.000358	0.0015	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—melanoma	0.000352	0.00148	CcSEcCtD
Idarubicin—Decreased appetite—Carmustine—melanoma	0.000351	0.00148	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—melanoma	0.000341	0.00143	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—melanoma	0.000341	0.00143	CcSEcCtD
Idarubicin—Hypersensitivity—Bleomycin—melanoma	0.00034	0.00143	CcSEcCtD
Idarubicin—Decreased appetite—Temozolomide—melanoma	0.000339	0.00143	CcSEcCtD
Idarubicin—Flushing—Docetaxel—melanoma	0.000339	0.00142	CcSEcCtD
Idarubicin—Angiopathy—Docetaxel—melanoma	0.000331	0.00139	CcSEcCtD
Idarubicin—Gastrointestinal pain—Carmustine—melanoma	0.00033	0.00139	CcSEcCtD
Idarubicin—Immune system disorder—Docetaxel—melanoma	0.00033	0.00139	CcSEcCtD
Idarubicin—Chills—Docetaxel—melanoma	0.000327	0.00138	CcSEcCtD
Idarubicin—Arrhythmia—Docetaxel—melanoma	0.000326	0.00137	CcSEcCtD
Idarubicin—Alopecia—Docetaxel—melanoma	0.000322	0.00136	CcSEcCtD
Idarubicin—Abdominal pain—Carmustine—melanoma	0.000319	0.00134	CcSEcCtD
Idarubicin—Body temperature increased—Carmustine—melanoma	0.000319	0.00134	CcSEcCtD
Idarubicin—Gastrointestinal pain—Temozolomide—melanoma	0.000319	0.00134	CcSEcCtD
Idarubicin—Malnutrition—Docetaxel—melanoma	0.000318	0.00134	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—melanoma	0.000318	0.00134	CcSEcCtD
Idarubicin—Urticaria—Temozolomide—melanoma	0.00031	0.0013	CcSEcCtD
Idarubicin—Abdominal pain—Temozolomide—melanoma	0.000308	0.0013	CcSEcCtD
Idarubicin—Body temperature increased—Temozolomide—melanoma	0.000308	0.0013	CcSEcCtD
Idarubicin—Hypersensitivity—Carmustine—melanoma	0.000297	0.00125	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—melanoma	0.000295	0.00124	CcSEcCtD
Idarubicin—Vomiting—Bleomycin—melanoma	0.000294	0.00124	CcSEcCtD
Idarubicin—Anaemia—Docetaxel—melanoma	0.000294	0.00124	CcSEcCtD
Idarubicin—Rash—Bleomycin—melanoma	0.000291	0.00123	CcSEcCtD
Idarubicin—Dermatitis—Bleomycin—melanoma	0.000291	0.00122	CcSEcCtD
Idarubicin—Daunorubicin—ABCB1—melanoma	0.000289	0.0323	CrCbGaD
Idarubicin—Hypersensitivity—Temozolomide—melanoma	0.000287	0.00121	CcSEcCtD
Idarubicin—Leukopenia—Docetaxel—melanoma	0.000284	0.0012	CcSEcCtD
Idarubicin—Diarrhoea—Carmustine—melanoma	0.000276	0.00116	CcSEcCtD
Idarubicin—Convulsion—Docetaxel—melanoma	0.000275	0.00116	CcSEcCtD
Idarubicin—Nausea—Bleomycin—melanoma	0.000275	0.00115	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—melanoma	0.000274	0.00115	CcSEcCtD
Idarubicin—Rash—Dactinomycin—melanoma	0.000272	0.00114	CcSEcCtD
Idarubicin—Chest pain—Docetaxel—melanoma	0.00027	0.00114	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000269	0.00113	CcSEcCtD
Idarubicin—Diarrhoea—Temozolomide—melanoma	0.000267	0.00112	CcSEcCtD
Idarubicin—Anaphylactic shock—Docetaxel—melanoma	0.000259	0.00109	CcSEcCtD
Idarubicin—Infection—Docetaxel—melanoma	0.000258	0.00108	CcSEcCtD
Idarubicin—Vomiting—Carmustine—melanoma	0.000256	0.00108	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—melanoma	0.000256	0.00108	CcSEcCtD
Idarubicin—Shock—Docetaxel—melanoma	0.000255	0.00107	CcSEcCtD
Idarubicin—Rash—Carmustine—melanoma	0.000254	0.00107	CcSEcCtD
Idarubicin—Dermatitis—Carmustine—melanoma	0.000254	0.00107	CcSEcCtD
Idarubicin—Thrombocytopenia—Docetaxel—melanoma	0.000254	0.00107	CcSEcCtD
Idarubicin—Headache—Carmustine—melanoma	0.000253	0.00106	CcSEcCtD
Idarubicin—Skin disorder—Docetaxel—melanoma	0.000252	0.00106	CcSEcCtD
Idarubicin—Vomiting—Temozolomide—melanoma	0.000248	0.00104	CcSEcCtD
Idarubicin—Anorexia—Docetaxel—melanoma	0.000247	0.00104	CcSEcCtD
Idarubicin—Rash—Temozolomide—melanoma	0.000246	0.00103	CcSEcCtD
Idarubicin—Dermatitis—Temozolomide—melanoma	0.000246	0.00103	CcSEcCtD
Idarubicin—Headache—Temozolomide—melanoma	0.000244	0.00103	CcSEcCtD
Idarubicin—Nausea—Carmustine—melanoma	0.00024	0.00101	CcSEcCtD
Idarubicin—Doxorubicin—ABCB1—melanoma	0.000234	0.0262	CrCbGaD
Idarubicin—Nausea—Temozolomide—melanoma	0.000232	0.000974	CcSEcCtD
Idarubicin—Decreased appetite—Docetaxel—melanoma	0.000225	0.000948	CcSEcCtD
Idarubicin—Gastrointestinal pain—Docetaxel—melanoma	0.000212	0.000892	CcSEcCtD
Idarubicin—Body temperature increased—Docetaxel—melanoma	0.000205	0.000862	CcSEcCtD
Idarubicin—Abdominal pain—Docetaxel—melanoma	0.000205	0.000862	CcSEcCtD
Idarubicin—Hypersensitivity—Docetaxel—melanoma	0.000191	0.000803	CcSEcCtD
Idarubicin—Diarrhoea—Docetaxel—melanoma	0.000177	0.000746	CcSEcCtD
Idarubicin—Vomiting—Docetaxel—melanoma	0.000165	0.000693	CcSEcCtD
Idarubicin—Rash—Docetaxel—melanoma	0.000163	0.000688	CcSEcCtD
Idarubicin—Dermatitis—Docetaxel—melanoma	0.000163	0.000687	CcSEcCtD
Idarubicin—Headache—Docetaxel—melanoma	0.000162	0.000683	CcSEcCtD
Idarubicin—Nausea—Docetaxel—melanoma	0.000154	0.000648	CcSEcCtD
Idarubicin—CYP2C9—Biological oxidations—CYP17A1—melanoma	6.42e-05	0.00149	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	6.39e-05	0.00148	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.36e-05	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.35e-05	0.00147	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	6.33e-05	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.32e-05	0.00146	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PTEN—melanoma	6.09e-05	0.00141	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	6.05e-05	0.0014	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	5.93e-05	0.00137	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2B—melanoma	5.89e-05	0.00136	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CUL3—melanoma	5.86e-05	0.00136	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TRRAP—melanoma	5.86e-05	0.00136	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.73e-05	0.00133	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	5.7e-05	0.00132	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKR1B10—melanoma	5.7e-05	0.00132	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.55e-05	0.00128	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP1B1—melanoma	5.45e-05	0.00126	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.42e-05	0.00126	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—E2F1—melanoma	5.41e-05	0.00125	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP1B1—melanoma	5.4e-05	0.00125	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	5.37e-05	0.00124	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	5.33e-05	0.00123	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PRKCA—melanoma	5.3e-05	0.00123	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.28e-05	0.00122	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PLCB4—melanoma	5.22e-05	0.00121	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	5.22e-05	0.00121	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.16e-05	0.0012	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.16e-05	0.00119	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—FASN—melanoma	5.12e-05	0.00119	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PCNA—melanoma	5.1e-05	0.00118	CbGpPWpGaD
Idarubicin—ABCC1—Disease—LUM—melanoma	5.08e-05	0.00118	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HPSE—melanoma	4.98e-05	0.00115	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	4.93e-05	0.00114	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TERT—melanoma	4.93e-05	0.00114	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.91e-05	0.00114	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC6A11—melanoma	4.91e-05	0.00114	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIP4K2A—melanoma	4.91e-05	0.00114	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	4.9e-05	0.00113	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CUBN—melanoma	4.89e-05	0.00113	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.87e-05	0.00113	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.79e-05	0.00111	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—MTAP—melanoma	4.78e-05	0.00111	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CSPG4—melanoma	4.73e-05	0.00109	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.67e-05	0.00108	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK2—melanoma	4.66e-05	0.00108	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RPS3—melanoma	4.65e-05	0.00108	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SKI—melanoma	4.58e-05	0.00106	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.48e-05	0.00104	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—ATM—melanoma	4.43e-05	0.00103	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK4—melanoma	4.41e-05	0.00102	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.33e-05	0.001	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	4.29e-05	0.000993	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LUM—melanoma	4.26e-05	0.000986	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PHGDH—melanoma	4.26e-05	0.000986	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HPSE—melanoma	4.17e-05	0.000967	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—melanoma	4.16e-05	0.000963	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CUBN—melanoma	4.1e-05	0.000949	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.09e-05	0.000947	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BSG—melanoma	3.96e-05	0.000916	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SDHD—melanoma	3.96e-05	0.000916	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CSPG4—melanoma	3.96e-05	0.000916	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RB1—melanoma	3.83e-05	0.000888	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GPAM—melanoma	3.83e-05	0.000888	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.82e-05	0.000886	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—IL6—melanoma	3.81e-05	0.000882	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HDAC6—melanoma	3.78e-05	0.000875	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	3.77e-05	0.000873	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.66e-05	0.000847	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—melanoma	3.65e-05	0.000846	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACER3—melanoma	3.63e-05	0.000841	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACER3—melanoma	3.6e-05	0.000834	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NPPA—melanoma	3.58e-05	0.000829	CbGpPWpGaD
Idarubicin—ABCC1—Disease—VCAN—melanoma	3.5e-05	0.000809	CbGpPWpGaD
Idarubicin—ABCC1—Disease—WNT5A—melanoma	3.47e-05	0.000803	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—melanoma	3.37e-05	0.00078	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	3.34e-05	0.000773	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UGT2B10—melanoma	3.32e-05	0.000769	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UGT2B10—melanoma	3.29e-05	0.000763	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—melanoma	3.27e-05	0.000757	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PLA2G6—melanoma	3.26e-05	0.000755	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.25e-05	0.000753	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	3.18e-05	0.000737	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HS3ST5—melanoma	3.09e-05	0.000715	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	3.08e-05	0.000713	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HS3ST5—melanoma	3.06e-05	0.000709	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1B—melanoma	2.98e-05	0.000691	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—VCAN—melanoma	2.93e-05	0.000678	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—melanoma	2.85e-05	0.000659	CbGpPWpGaD
Idarubicin—ABCC1—Disease—GAB2—melanoma	2.78e-05	0.000645	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.77e-05	0.000642	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1A—melanoma	2.75e-05	0.000638	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FASN—melanoma	2.73e-05	0.000631	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.67e-05	0.000619	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	2.63e-05	0.000608	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HDAC2—melanoma	2.62e-05	0.000606	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CXCR4—melanoma	2.62e-05	0.000606	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FOXO4—melanoma	2.62e-05	0.000606	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD44—melanoma	2.59e-05	0.0006	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	2.55e-05	0.000591	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	2.5e-05	0.000579	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP17A1—melanoma	2.47e-05	0.000572	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.46e-05	0.000571	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.44e-05	0.000564	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.4e-05	0.000557	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT3—melanoma	2.39e-05	0.000553	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK3—melanoma	2.35e-05	0.000544	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PLCB4—melanoma	2.34e-05	0.000542	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNA11—melanoma	2.33e-05	0.00054	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PLCB4—melanoma	2.32e-05	0.000537	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	2.29e-05	0.000529	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—melanoma	2.28e-05	0.000529	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—FASN—melanoma	2.28e-05	0.000529	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	2.28e-05	0.000527	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC5A5—melanoma	2.25e-05	0.00052	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK1—melanoma	2.23e-05	0.000517	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC6A11—melanoma	2.2e-05	0.00051	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIP4K2A—melanoma	2.2e-05	0.00051	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIP4K2A—melanoma	2.18e-05	0.000505	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC6A11—melanoma	2.18e-05	0.000505	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNAQ—melanoma	2.17e-05	0.000502	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CD44—melanoma	2.17e-05	0.000502	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTAP—melanoma	2.14e-05	0.000496	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.12e-05	0.000492	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTAP—melanoma	2.12e-05	0.000492	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB4—melanoma	2.11e-05	0.000489	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.1e-05	0.000487	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—melanoma	2.09e-05	0.000484	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1B1—melanoma	2.08e-05	0.000481	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.07e-05	0.00048	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD86—melanoma	2.02e-05	0.000469	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF1—melanoma	1.96e-05	0.000454	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PHGDH—melanoma	1.91e-05	0.000442	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LUM—melanoma	1.91e-05	0.000442	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFRA—melanoma	1.9e-05	0.00044	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LUM—melanoma	1.89e-05	0.000438	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PHGDH—melanoma	1.89e-05	0.000438	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PRKCA—melanoma	1.88e-05	0.000436	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—melanoma	1.88e-05	0.000434	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HPSE—melanoma	1.87e-05	0.000433	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERCC2—melanoma	1.87e-05	0.000432	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HPSE—melanoma	1.86e-05	0.00043	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAP2K2—melanoma	1.84e-05	0.000426	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CUBN—melanoma	1.84e-05	0.000425	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.83e-05	0.000425	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CUBN—melanoma	1.82e-05	0.000422	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CSPG4—melanoma	1.77e-05	0.000411	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BSG—melanoma	1.77e-05	0.000411	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SDHD—melanoma	1.77e-05	0.000411	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SDHD—melanoma	1.76e-05	0.000407	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BSG—melanoma	1.76e-05	0.000407	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CSPG4—melanoma	1.76e-05	0.000407	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HLA-A—melanoma	1.75e-05	0.000405	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TERT—melanoma	1.75e-05	0.000405	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RAC1—melanoma	1.74e-05	0.000404	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPAM—melanoma	1.72e-05	0.000398	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—melanoma	1.71e-05	0.000396	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPAM—melanoma	1.7e-05	0.000394	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—melanoma	1.67e-05	0.000387	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PRKCA—melanoma	1.58e-05	0.000365	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ERCC2—melanoma	1.56e-05	0.000362	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS2—melanoma	1.52e-05	0.000352	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—melanoma	1.51e-05	0.000349	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD80—melanoma	1.48e-05	0.000342	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—melanoma	1.47e-05	0.000341	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—melanoma	1.47e-05	0.000341	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PLA2G6—melanoma	1.46e-05	0.000338	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGF—melanoma	1.46e-05	0.000337	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PLA2G6—melanoma	1.45e-05	0.000335	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—melanoma	1.38e-05	0.000321	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—VCAN—melanoma	1.31e-05	0.000304	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAP2K1—melanoma	1.3e-05	0.000302	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—VCAN—melanoma	1.3e-05	0.000301	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CD—melanoma	1.3e-05	0.0003	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.29e-05	0.0003	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF2—melanoma	1.24e-05	0.000287	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—melanoma	1.23e-05	0.000286	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.23e-05	0.000285	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARG—melanoma	1.19e-05	0.000276	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.19e-05	0.000275	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—melanoma	1.16e-05	0.000269	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—melanoma	1.14e-05	0.000265	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CB—melanoma	1.13e-05	0.000261	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD4—melanoma	1.13e-05	0.000261	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—melanoma	1.12e-05	0.000259	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP17A1—melanoma	1.11e-05	0.000256	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP17A1—melanoma	1.1e-05	0.000254	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CD—melanoma	1.08e-05	0.000251	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.08e-05	0.000251	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALB—melanoma	1.07e-05	0.000248	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.07e-05	0.000247	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1B—melanoma	1.06e-05	0.000245	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNA11—melanoma	1.05e-05	0.000242	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNA11—melanoma	1.04e-05	0.00024	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—FASN—melanoma	1.02e-05	0.000237	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—FASN—melanoma	1.01e-05	0.000235	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A5—melanoma	1.01e-05	0.000233	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CTNNB1—melanoma	1e-05	0.000232	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A5—melanoma	9.98e-06	0.000231	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—melanoma	9.78e-06	0.000226	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—melanoma	9.76e-06	0.000226	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNAQ—melanoma	9.72e-06	0.000225	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CD44—melanoma	9.72e-06	0.000225	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNAQ—melanoma	9.64e-06	0.000223	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CD44—melanoma	9.64e-06	0.000223	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CB—melanoma	9.46e-06	0.000219	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.44e-06	0.000219	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—melanoma	9.37e-06	0.000217	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.35e-06	0.000217	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1B1—melanoma	9.32e-06	0.000216	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1B1—melanoma	9.24e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—melanoma	8.73e-06	0.000202	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NRAS—melanoma	8.7e-06	0.000202	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—melanoma	8.34e-06	0.000193	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—melanoma	8.17e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.15e-06	0.000189	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—melanoma	8.11e-06	0.000188	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK1—melanoma	7.93e-06	0.000184	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—melanoma	7.93e-06	0.000184	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—melanoma	7.67e-06	0.000178	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—melanoma	7.61e-06	0.000176	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—melanoma	7.49e-06	0.000173	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PRKCA—melanoma	7.06e-06	0.000164	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ERCC2—melanoma	7e-06	0.000162	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PRKCA—melanoma	7e-06	0.000162	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ERCC2—melanoma	6.94e-06	0.000161	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—melanoma	6.88e-06	0.000159	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—melanoma	6.37e-06	0.000147	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—melanoma	6.09e-06	0.000141	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—melanoma	5.76e-06	0.000133	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.75e-06	0.000133	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—melanoma	5.62e-06	0.00013	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—melanoma	5.53e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—melanoma	5.48e-06	0.000127	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARG—melanoma	5.34e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARG—melanoma	5.29e-06	0.000123	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CD—melanoma	4.86e-06	0.000113	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CD—melanoma	4.82e-06	0.000112	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALB—melanoma	4.8e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALB—melanoma	4.76e-06	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—melanoma	4.71e-06	0.000109	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CB—melanoma	4.24e-06	9.82e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CB—melanoma	4.2e-06	9.73e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—melanoma	4.2e-06	9.73e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—melanoma	4.16e-06	9.64e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—melanoma	3.66e-06	8.48e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—melanoma	3.63e-06	8.41e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—melanoma	2.58e-06	5.98e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—melanoma	2.56e-06	5.93e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—melanoma	2.11e-06	4.89e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—melanoma	2.09e-06	4.85e-05	CbGpPWpGaD
